Talcum Powder Lawsuit: Inside the Johnson & Johnson Case

This page reads about the ongoing talcum powder lawsuit involving Johnson & Johnson and other manufacturers. This case revolves around allegations that the long-term use of talc-containing products may be associated with ovarian cancer and other health problems.

The following sections explicate the background, vital developments, progress in settlement, and the present status of the case. This has been designed in such a way that it helps the readers understand how litigation has progressed till now and what it may mean for consumers and claimants seeking accountability and fair compensation.

What the Talcum Powder Lawsuit Is About?

The talcum powder trial concerns accusations against Johnson & Johnson and others for having marketed talc-based products that could have contained asbestos, a known carcinogen, without giving any warning to the consumer. Numerous women allege that using these products regularly for personal hygiene led to ovarian cancer or mesothelioma.

The lawsuits allege that the companies knew of and could have foreseen some of the risks but neglected to warn customers and thereby put millions of users in harm’s way. These allegations have led to thousands of lawsuits across the United States, where the plaintiffs are seeking justice, compensation, and accountability from the manufacturers for the damage inflicted.

News on J&J Talcum Powder Lawsuit Update (2026)

The legal team is attempting to keep you updated regarding the litigation on Johnson & Johnson talcum powder. Considerable twists have marked this case along its path, and it continues to impact discussions about consumer safety and corporate accountability.

Here you will find news and key developments, thus keeping you abreast of this important legal matter which directly affects vast arrays of individuals and families.

August 28, 2025: Settlement Negotiation Framework Finalised

The leadership structure has been established by the court for conducting settlement negotiations in the J&J talc MDL. A Lead Negotiation Counsel and a two-member Plaintiffs’ Negotiation Committee have been appointed to facilitate the mediation process to interact with plaintiffs’ counsel, ultimately reporting directly to the court.

The first mediation session will be set up for September 4, 2025, in Trenton, with the requirement of full attendance by both parties, including defense representatives with full settlement authority. If a global settlement cannot be reached through mediation, then the court will proceed with the bellwether trials, starting with an ovarian cancer case that is expected to provide guidance on subsequent trials. The purpose of the structured negotiations is to promote settlement but keep alive the pressure and urgency of the impending trials.

August 13, 2025: Court Expands Liability to Additional J&J Entities

A federal judge presiding over the talcum powder multi-district litigation showed that the plaintiffs can involve Kenvue Inc., Janssen Pharmaceuticals Inc., and Johnson & Johnson Holdco Inc. as part of the master complaint. This ruling affirms previous findings from a special master, which stated that these entities plausibly continued with the manufacturing and sale of baby powder after corporate restructurings of the Johnson and Johnson manufacturing operations.

Judge Shipp purported that these affiliates were too far removed to be dragged through liability, nonetheless, plaintiffs presented credible allegations naming them as successors to the original talc operations of the company. However, this ruling, which also aligns with a corresponding one in New Jersey state court, also furthers the plaintiffs’ position while restricting the chances for J&J to further hide its assets through bankruptcy. The company will also face increased pressure when the first trial under MDL approaches, giving suffering parties an even greater advantage for negotiations regarding compensation and responsibility.

August 7, 2025: Former MDL Judge Returns as Special Master

Judge Freda Wolfson, retired in 2023, was the head judge for the talcum powder MDL over a seven-year span and has now rejoined the litigation under another capacity as master. In her new function, she has reviewed the same scientific evidence she previously approved as a presiding judge.

Judge Wolfson has since joined Lowenstein Sandler, the firm that represents Johnson & Johnson in other matters; however, she has formally recused herself from all J&J-related work within the firm. This separation has been documented in a waiver that has been filed with the court. Reappointment, while unusual, is embraced by both sides and shows the court’s intention in reappointing her due to her rich familiarity with the complex scientific and procedural background of the talc litigation.

August 1, 2025: Massachusetts Jury Awards $42.6 Million in Talc Verdict

A jury in Massachusetts ruled that Johnson & Johnson would pay around $42.6 million, clearly identifying the company’s talc-based baby powder as a long-term causative factor for the mesothelioma that the plaintiff developed. As always, the company was false to its stock defense of denying any association with asbestos, challenging scientific evidence, and promising to appeal.

An ever-increasing list of verdicts against Johnson & Johnson over all talc-related cases on asbestos culminates in strong evidence and testimony from juries against Johnson’s denial of liability. Despite successive losses, the company continues to expose itself to ever-worsening legal and financial consequences since courts have upheld findings of negligence and failure to warn its consumers.

July 14, 2025: Another Talc Trial Begins in Boston

A new talcum powder trial began in Boston just after a local jury awarded $8 million in a similar case. The plaintiff claims that decades of using Johnson and Johnson baby powder resulted in mesothelioma because of the company’s concealment of evidence about asbestos contamination from the public and regulatory agencies. 

Johnson & Johnson continues to deny any liability, attributing the cause of the ailment to some rare genetic mutation rather than exposure to its products. However, the latest jury verdicts where millions were awarded for both past and future damages seem to indicate that jurors were not persuaded by the defence strategy of the company.

July 3, 2025: Court Appoints Mediator for Talc Settlement Discussions

The federal court supervising the multidistrict litigation (MDL) involving Johnson & Johnson talcum powder has appointed a mediator for settlement talks, despite the company’s inclination against mediation. 

Under the order of the court, Mr. Kurdi will streamline the process and govern participation as well as guide both parties through confidential negotiation sessions, making it possible that all of them are required to participate in good faith and to have full settlement authority.

Such an intention proves that the court will explore a potential global resolution, while at the same time keeping the option of trial preparation available. Although Johnson & Johnson has continued focusing on litigation, the appointment draws a fine line between ongoing proceedings in the courts and the structured opening for negotiation.

July 1, 2025: First Bellwether Trial Selected in Federal Talc Litigation

The first bellwether case has been chosen in the Johnson & Johnson talc MDL, which has now been consolidated into 63693 lawsuits. The case selected, Judkins v. Johnson & Johnson, is that of a woman from New Hampshire alleging that she developed ovarian cancer after decades of using Johnson’s Baby Powder.

The case, filed in 2019, is expected to be one test case that juries will look to evaluate claims of Johnson & Johnson marketing talc-based feminine hygiene products while hiding potential risks of ovarian cancer and asbestos contamination. While the verdict will not impose direct consequences on all the other claims, settlements, and the general litigation approach will very much be swayed by it. 

Having been diagnosed with ovarian cancer in 2016, the plaintiff had used the product for well over 30 years. Jurors and experts will analyze internal company documents suggesting that Johnson & Johnson had long been cognizant of asbestos traces in its talc. The verdict will also direct how federal jurors interpret the company’s conduct and scientific evidence henceforth.

June 29, 2025: $8 Million Verdict in Massachusetts Talc Trial

A jury in Suffolk County has awarded an $8 million judgment against Johnson & Johnson to a Massachusetts woman who developed mesothelioma after years of using the company’s talc-based products. The jury held the company liable for negligence and breach of warranty, concluding that asbestos contamination in the company’s baby powder caused her illness. 

The verdict adds to the long line of losses for the company in the courts, further raising the question of why the company continues to defend these suits rather than settle. Each adverse verdict serves to tarnish the company’s reputation further while each carries legal fees, appeal expenses, and increasing awards from juries that negatively impact the company financially.

June 17, 2025: Philadelphia Court Launches New Talc Mass Tort Program

The Philadelphia Court of Common Pleas has put in place a special mass tort program for cases related to ovarian cancer lawsuits surrounding Johnson & Johnson’s talcum powder. Already on the docket are 26 cases with more to come in the following months. Two bellwether trials are slated for early 2026, which further indicates the court’s intention to expedite those claims through the system.

Read about the Batiste Dry Shampoo Cancer Lawsuit

This adds to what is already a significant litigation front against Johnson & Johnson, which currently faces thousands of such claims in the federal MDL. The announcement also raises the question of why the corporation seems to have made the deliberate choice to continue putting these cases to trial even as the record of verdicts grows ever more expensive and damaging to its reputation.

May 29, 2025: The Current State of the Talcum Powder Litigation

The talcum powder lawsuits have resumed their active run at the end of May. The proposed settlement plan of $8.9 billion is no longer being considered, and the courts have rejected the bankruptcy plan of Johnson & Johnson. There are around 50,000 active lawsuits with more being continuously filed. 

Soon, trials would begin, and this situation would only intensify pressure on the company to reach an acceptable settlement. Anyone who previously filed a lawsuit against them is once again eligible; also, anyone who has not yet filed will have the opportunity to join the litigation before any deadlines can be set.

May 27, 2025: Rejection of Bankruptcy Plan Puts Pressure on Talc Attorneys

Bloomberg stated that there are now serious challenges arising for attorneys representing victims of the talcum powder litigation since the U.S. Bankruptcy Court dismissed a proposed $9 billion bankruptcy settlement sent forth by Johnson & Johnson. The rejected bankruptcy scheme, which was formulated to extinguish over 60,000 pending cases, has left law firms that have invested fortunes with a daunting task: they must now re-file approximately 30,000 individual lawsuits across numerous civil courts before the expiration of limitation periods. 

This process will necessitate enormous financial and logistical resources; high filing fees are involved, and recovery timeframes remain highly uncertain. In spite of all these hurdles, plaintiff counsel are nevertheless determined to stay focused on their main goal: to try and obtain the maximum possible compensation for all those injured by Johnson & Johnson’s talc-based products.

April 11, 2025: Litigation Resumes After Johnson & Johnson’s Third Bankruptcy Failure

The talcum powder federal litigation moves forward again after Johnson & Johnson’s third bankruptcy attempt failed. A few days ago, the bankruptcy court determined that the $9 billion reorganization plan of the company had not attained the effective legal standard that would have shielded it from continuing liability. Johnson & Johnson stated it would not appeal in order for the present litigation to move forward without further delay. 

The multidistrict litigation currently includes over 90,000 cases claiming that talc-based powders, including Baby Powder and Shower-to-Shower, were contaminated with asbestos to the point that they caused ovarian cancer after long-term use. Although some major verdicts have been issued for plaintiffs by several state courts, no federal MDL cases have gone to trial yet, but that is expected to change now. 

Judge Shipp has required the parties to inform the court concerning the status of any pretrial motions and trial preparedness. Key scientific admissibility issues under Rule 702 are being reviewed, marking a highly important step toward setting the first bellwether trial. Now that the Johnson & Johnson bankruptcy tactics are no longer a hurdle to plaintiffs’ cases, the early federal verdicts could heavily sway settlement discussions.

March 31, 2025: Court Rejects Johnson & Johnson’s Third Bankruptcy Attempt

Bankruptcy judge of the United States Christopher Lopez has dismissed Johnson & Johnson’s third petition for availing of the bankruptcy remedy to settle tens of thousands of lawsuits related to cancer caused by talcum powder. Initially, this liability was to be routed through a newly established subsidiary under Chapter 11, Red River Talc LLC. However, Judge Lopez said that the pre-filing vote among the 93,000 claimants was “fundamentally flawed” and was taken under “an unreasonably short voting time,” hence criticizing the company’s approach as hastily complying with the required approval threshold for clearance.

This pronouncement manifests one major judicial rebuff to Johnson & Johnson’s ever-ongoing attempts to utilize bankruptcy to manage tremendous tort liability while being solvent. The Third Circuit had already rejected previous bankruptcy filings on similar grounds, leading the company to move to the Fifth Circuit, which has generally shown itself to be friendlier to corporations. Even so, this recent ruling has clarified that such strategies would not shield financially stable defendants from the jury trial process.

Around the corner is an appeal from Johnson & Johnson, though lawyers judge their chances to be slim. With the ruling, conventional litigation is again facilitated, with a cash flow granted for plaintiffs to move toward trial. Essentially, this means renewed advances for victims to seek accountability and compensation for what they allege to be the contaminating effects of the asbestos in Johnson & Johnson’s talc-based products. It further reaffirms that bankruptcy laws were not to be exploited to avoid a jury trial or limit access to justice.

February 19, 2024: Bankruptcy Trial Begins in Texas

One of the key hearings on the question of the validity of the third bankruptcy filing by Johnson & Johnson in connection with the talcum powder litigation began this week in Texas. U.S. Bankruptcy Judge Christopher Lopez will oversee the two-week hearing with testimony from as many as 40 witnesses. The hearings center on whether Red River Talc LLC, a subsidiary of J&J, filed its Chapter 11 petition in bad faith and whether voting irregularities vitiated the legitimacy of the proposed $10 billion settlement plan. 

Plaintiffs’ attorneys are split on this matter—with some opposing the bankruptcy, asserting that client votes were improperly influenced and that the plan undermines victims’ rights to pursue claims in civil court, while others feel a negotiated settlement is better after years of litigation delays without compensation. The outcome of the trial will determine whether the bankruptcy can continue or whether J&J must revert to the normal litigation track.

January 28, 2024: Settlement Holdouts Challenge Bankruptcy Plan

Opposition to the proposed $8 billion bankruptcy settlement of Johnson & Johnson is growing. The Coalition of Counsel for Justice, a group of plaintiffs, believes that the plan denies victims access to a jury trial. This group also contests J&J’s assertion that more than 80 percent of claimants support the deal by citing several defects in the voting process. 

Pursuant to the plan, J&J’s subsidiary Red River Talc would set up a trust to pay claims based on predetermined criteria and effectively halt all ongoing and future litigations. Opponents argue that there is no proof of adequate funding and that it is therefore not compliant with laws on asbestos bankruptcies. Johnson & Johnson claims that the settlement affords the victims relatively certain compensation without the uncertainties of trial verdicts. Key court decisions are expected to be made in the coming weeks.

January 24, 2024: Why Johnson & Johnson Is Pushing for Bankruptcy Resolution

Johnson & Johnson is pushing for the resolution of its talcum powder lawsuits in bankruptcy mainly because of the greater control and predictability. In a Chapter 11 proceeding, this means limiting the financial exposure of the company by amalgamating the tens of thousands of claims into one singular trust-based system. Such a model halts jury trials, prevents new lawsuits, and ensures standardized payouts predicated on specific eligibility criteria.

By routing all claims through bankruptcy, J&J will limit exposure to potentially unpredictable jury verdicts and keep the liability within single-digit millions to very modest compensatory awards and as much as multibillion-dollar punitive damages. Thereby, the bankruptcy process allows the company essentially to impose order and cost certainty over what remains one of the largest mass tort litigations in America’s history.

December 5, 2023: Legislative Push to End Bankruptcy Abuse

Senator Elizabeth Warren has reintroduced the Nondebtor Release Prohibition Act of 2024, targeting the bankruptcy tactics of corporations that allow solvent companies to escape liability through loopholes in the law. Among other objectives, the bill seeks to prohibit non-consensual litigation shields for nonbankrupt entities and codify the recent Supreme Court ruling in Harrington v. Purdue Pharma, which prevented the Sackler family from obtaining liability releases in the Purdue Pharma bankruptcy.

The legislation specifically works against the “Texas Two-Step” strategy which is used by companies like Johnson & Johnson – forming a new subsidiary to incur mass tort claims and then placing the subsidiary into bankruptcy. If enacted, those bankruptcy filings involving divisional mergers from the last 10 years would automatically be invalidated, as well as liability releases that would require affirmative, specific consent from creditors.

While this proposal was once perceived as a partisan initiative, it is now attracting support across the aisle amid rising public outrage over corporate misuse of bankruptcy shields. The action presents a direct threat to Johnson & Johnson’s talc litigation strategy, making it ineffective against future attempts to isolate liability through bankruptcy restructuring.

December 3, 2023: Litigation on Hold Until March

The bankruptcy court has mandated that, as of today, the stay applied to lawsuits against Johnson & Johnson for talcum powder is valid until the middle part of March, during which time Johnson & Johnson will further pursue its intended bankruptcy plan. This plan will fund a potential $8 billion settlement via Red River Talc LLC, its subsidiary, to resolve tens of thousands of cancer claims. 

During the latest hearing, the court both denied a plea to extend the litigation freeze to encompass related entities and also rejected a request to lift the stay for the individual suits. A trial to determine whether Judge Christopher Lopez will approve the proposed reorganization plan has been set for late January.

November 14, 2023: DOJ Challenges J&J’s Counsel

The Department of Justice (DOJ), through the Office of the United States Trustee, has objected to Johnson & Johnson’s selection of Jones Day, the law firm to represent its subsidiary Red River Talc LLC in an ongoing bankruptcy case. The objection cites a clear conflict of interest since Jones Day actually helped shape the same Texas Two-Step legal strategy now being called into question. 

Increased scrutiny of corporate liability-limiting bankruptcy practices has now entered the public forum because of the DOJ’s intervention. This could become a precedent for future courts as they consider law firm conflicts in mass tort reorganizations.

October 15, 2023: $15 Million Connecticut Verdict

The case was brought by a real estate developer against Johnson and Johnson and its subsidiaries in Connecticut, where the jury instructed the company to pay $15 million in damages. The plaintiff alleged that his terminal illness was caused by long-term exposure to asbestos-tainted talcum powder. The verdict strengthens the building judicial consensus that J&J’s talc-based products do pose health hazards associated with asbestos, and it puts pressure on the company as litigation continues across the country.

October 12, 2023: Connecticut Mesothelioma Jury Deliberations

In the Connecticut mesothelioma trial involving a Massachusetts real estate developer who has blamed his cancer diagnosis on decades of exposure to Johnson & Johnson’s baby powder, jury deliberations were beginning. The plaintiff’s legal team had asked for $30 million in damages, while J&J were asking for a considerably lesser sum of $4 million and argued that the disease arose from a genetic mutation rather than from asbestos exposure. 

The outcome was thought to be telling regarding jurors’ opinions of the company’s persisting defense strategy in these cases, which is very much under scrutiny in courtrooms all across the country.

September 30, 2023: U.S. Trustee Accuses J&J of Forum Shopping

The U.S. Trustee presiding over Johnson & Johnson’s third talc bankruptcy proceeding has accused the company of “forum shopping,” alleging that it purposely filed the case in Texas for the benefit of a more favourable court. In a motion seeking to transfer the case to New Jersey, the Trustee contended that Red River Talc LLC, J&J’s new subsidiary, is practically the same entity as its former spinoff, LTL Management, holding identical assets and liabilities. The Trustee stated that the J&J move compromises the integrity of the bankruptcy system and appears aimed at escaping unfavourable rulings that were handed down in New Jersey.

September 25, 2023: Texas Bankruptcy Judge Temporarily Halts Some Lawsuits

A Texas bankruptcy judge has put on hold a number of talcum powder litigation against Johnson & Johnson in the meantime while jurisdictional questions are being resolved in the Chapter 11 case of Red River Talc LLC, the Company’s latest offshoot. The Company was formed to deal with talc claims and is proposing a $9 billion settlement plan for victims. The main question is whether J&J can legally pursue that course of action in Texas.

September 23, 2023: J&J Files Third Bankruptcy with $8 Billion Settlement Proposal

For the third time, a talc subsidiary of Johnson & Johnson, Red River Talc LLC, has filed for Chapter 11 bankruptcy, introducing a pre-packaged plan supported by 83% of current plaintiffs. Under this plan, an $8 billion settlement fund would be created for the compensation of ovarian cancer victims, attempting to resolve almost all claims, with mesothelioma cases treated separately. This renewed effort therefore constitutes yet another attempt by J&J to use the bankruptcy courts to contain its growing talc liability.

September 20, 2023: Confusion Over Settlement Details

Reports have surfaced suggesting that Johnson & Johnson’s possible settlement amount has dropped from $9.1 billion to $8.2 billion. Yet the plaintiffs have no idea how payouts would be calculated or distributed. The lack of transparency and shifting numbers frustrate the claimants and fuel the growing perception that the talc litigation process continues to be disarrayed and inconsistent.

September 9, 2023: Total Settlement to Exceed $9 Billion

Johnson and Johnson are currently making headlines for the fact that they intend to put in an extra $1.1 billion on top of their present talc settlement, which would raise the total to more than $9 billion to be paid over a period of 25 years. The settlement has been proposed in order to close off thousands of claims that relate its talc-based products to cancer.

Read about the CPAP Lawsuit

August 22, 2023: J&J Seeks Dismissal of Medical Monitoring Class Action

Johnson & Johnson has requested a federal judge to dismiss a suggested nationwide class action, which seeks funding for medical monitoring of individuals exposed to its talc products. The case states that ongoing health screenings are needed by users to detect potential cancers as early as possible. Critics say that whilst the intention is good, such cases usually end up giving little or nothing to the individuals concerned and divert attention from people who have already suffered.

August 16, 2023: $63 Million Verdict in South Carolina Talc Trial

A South Carolina jury has awarded $63.4 million to a man suffering from terminal lung cancer due to asbestos exposure from Johnson & Johnson’s baby powder. The jury found both J&J and American International Industries responsible for negligence, awarding them both compensatory and punitive damages. This judgment reiterates the pervasive risks that J&J continues to face in mesothelioma trials being held across the country.

August 12, 2023: Majority of Claimants Reportedly Support Settlement Plan

It is still too early to know the exact figures, but preliminary indications show that more than 75% of talc claimants have voted in favor of Johnson & Johnson’s latest proposal for settlement. Official results have not yet been declared, but judging by these numbers, it seems that there is overwhelming support for the resolution of claims via the proposed bankruptcy plan.

July 26, 2023: Court Rules J&J Bankruptcy Filed in Bad Faith

The Third Circuit affirmed the ruling that dismissed the bankruptcy case of LTL Management, a subsidiary of Johnson & Johnson, on the basis of good faith filing. The court did not find the company to be in financial distress, rejecting the argument of J&J that a prospective insolvency situation warranted the filing. This ruling dealt another major blow to J&J’s plan to use bankruptcy to limit liabilities arising from talc.

July 25, 2023: Voting on Settlement Plan Ends Tomorrow

With only a few hours till the deadline, claimants have time until 4:00 p.m. (Central Time) tomorrow to cast their votes to either accept or reject Johnson & Johnson’s proposed settlement plan. The program obliges J&J and its affiliates to provide a present-day value of nearly $6.475 billion over 25 years to set up a trust fund for the compensation of current and future victims of talc-associated cancers and pay claimants for ovarian cancer related to talc.

If at least 75% of claimants support the plan, it initiates a bankruptcy case titled In re: Red River Talc LLC in bankruptcy court, followed by a confirmation hearing. While a significant number of plaintiff lawyers initially opposed the settlement proposal, they eventually seem to have switched sides and now favor it. However, the outcome of the vote is still uncertain.

July 9, 2023: WHO Study Links J&J Talc Exposure to Cancer

The latest assessment of the World Health Organization now determines that making use of talcum powder from Johnson & Johnson likely raises the dangers of developing cancer, especially ovarian cancer. This is yet another enormous setback to the long-lived counterclaim of J&J that talc does not connect to cancer. What critics once viewed as speculation is now being proved by authorities worldwide as actual judgment.

July 3, 2023: Claimants to Vote on $6.5 Billion Settlement Proposal

J&J offered a settlement of $6.5 billion so that thousands of lawsuits surrounding ovarian cancer could be terminated. The proposal would require the approval of 75% of claimants by the end of the month. It is also trying to disqualify a law firm involved in the litigation, alleging ethical violations in a manner perceived by many as retaliation against opposing counsel. 

As the battle for those votes continues, this month should be about access to just compensation for victims rather than corporate distractions.

July 2, 2023: J&J Loses Lawsuit Against Expert Witness

The lawsuit by Johnson and Johnson against Dr. Jacqueline Moline, a medical expert for talc plaintiffs, has been tossed. The company had accused her of making statements that were false with respect to asbestos exposure in a 2019 study linking its baby powder to mesothelioma. The New Jersey federal judge ruled that her statements were protected under the First Amendment. 

This ruling is yet another setback for J&J in its attempts to discredit scientific experts standing on behalf of the victims in the talc litigation.

June 30, 2023: Court Likely to Allow Bankruptcy Settlement

By denying some claimants’ request for a temporary restraining order, a federal judge has allowed Johnson & Johnson to proceed with a possible settlement of its talc-powder lawsuits through bankruptcy. The court found that claimants had failed to show even a semblance of actual harm and that concerns of future damage were speculative. This clears the way for the all-important settlement vote at the end of the month.

June 26, 2023: Settlement Outcome Still Uncertain

Discussions among various legal counsel suggest that opinions about the talc powder settlement have shifted favorably, although some opposition remains. Some groups of plaintiffs object to the deal, making the July vote critical in determining whether it moves forward.

June 13, 2023: Lawyers Divided on Settlement Plan

Johnson & Johnson’s settlement offer is being equally recommended and rejected among the plaintiffs’ lawyers. While many believe it is the most sensible resolution, others see it as one that undervalues the pain inflicted and that J&J is escaping accountability.

June 7, 2023: New Talc Cancer Trial in Texas

The new talcum powder cancer trial started in Dallas, making it the first Texas trial in this litigation. Opening statements began on Wednesday, and the case settled shortly after proceedings commenced. 

June 4, 2023: Oregon Jury Awards $260 Million

Kyung Lee, who was diagnosed with mesothelioma due to years of baby powder use, was awarded $260 million by the jury, including $200 million in compensatory damages and $60 million in punitive damages, against Johnson & Johnson.

May 21, 2023: New Research Strengthens Plaintiffs’ Claims

In an extensive study published in the Journal of Clinical Oncology, researchers at NIH associated genital talc use with the occurrence of ovarian cancer. This research demonstrates the point that long-term exposure to talc increases the risk of ovarian cancer. Hence, it works against J&J’s arguments for safe products, and the settlement negotiations might be gravely affected due to this finding.

May 1, 2023: J&J Agrees to $6.5 Billion Settlement

The talc subsidiary of Johnson & Johnson committed itself to a $6.5 billion global settlement through its third bankruptcy scheme to settle all ovarian cancer lawsuits against it. The settlement does not cover the very few cases of mesothelioma that have been mostly settled. A vote for the final claimants will be held on July 26, 2023.

April 30, 2023: J&J Raises Offer to $8.9 Billion

The settlement funds offered by Johnson & Johnson to pay for breast talcum powder lawsuits have increased to $8.9 billion in a desperate attempt to get all conflicts settled through bankruptcy. The new proposal comes as a shot from an ill-fated $2 billion offer widely criticized and rejected. The company claims to have strong support from a sizeable section of the plaintiffs and lawyers, but it is not clear whether the required 75% was met for plan confirmation under bankruptcy. Many attorneys holding large inventories of cases are still opposing the plan.

April 25, 2023: Lawyers and Victims Divided on Settlement

The talc cancer claimants are seeking to have the court dismiss the second bankruptcy case that has been filed by the subsidiary of J&J, LTL Management LLC. They argue that the company is not financially distressed and that the filing is in bad faith. According to the company, its new $8.9 billion settlement proposal enjoys “significant support” from companies representing around 60,000 claimants. The legal community, however, remains polarized on whether it is a proper settlement or yet another mischief with the bankruptcy system.

April 21, 2023: Judge Allows New Talc Lawsuits to Proceed

According to a ruling made by the bankruptcy judge, Johnson & Johnson is required to keep finding itself in another series of lawsuits regarding claims that its talc-based baby powder gives rise to cancer. Presently, this judgment has put all existing lawsuits on hold for an additional 60 days; however, new lawsuits can be lodged and prepared. The judge, who did not seem convinced about J & J’s attempt to run behind another bankruptcy move, asked the parties involved to proceed with it.

April 13, 2023: Mixed Reactions to $8.9 Billion Settlement Offer

Reactions about the planned $8.9 billion settlement by Johnson & Johnson remain sharply divided. Leadership lawyers in the MDL argue that this amount is nowhere near sufficient for the approximately 70,000 cancer victims and insist that J&J should either up its offer or proceed to individual trials for each victim. Other firms representing tens of thousands of clients support the deal, citing victims’ immediate financial and health-related needs. The schism also underlines an increasing tension between the pursuit of maximum compensation and the timely relief of the plaintiffs.

April 12, 2023: J&J’s Second Bankruptcy Attempt Explained

Many people have been asking how Johnson & Johnson could file a second bankruptcy application when the first one ended up being a failure. Bankruptcy, the company argues, will be the most equitable and efficient means of settling the existing and future talc claims, while critics contend that this is nothing but a plan to limit payouts. The 3rd Circuit had ruled that J&J’s first bankruptcy was not valid because its subsidiary LTL Management was not in financial distress because of J&J’s promise of unlimited funding. This time, J&J restructured that promise, claiming compliance, while opponents accuse it of a $50 billion “fraudulent transfer” to sidestep accountability.

April 10, 2023: New Jersey Law Reveals Litigation Funding Details

A Bloomberg article spotlighted a new New Jersey statute that mandates disclosure in litigation funding and reveals the financial backers behind many baby powder lawsuits. Money from firms such as Virage Capital Management and TRGP Capital has backed hundreds of talc claims in exchange for a share of possible settlements. The rule seeks to regulate third-party funding to allow fairness in mass tort cases. With over 60,000 lawsuits against it, J&J has put forward an $8.9 billion global settlement. The disclosure law offers insights into how litigation funders help ensure a level playing field for the plaintiffs against large corporations.

April 4, 2023: Court Denies J&J’s Request to Extend Case Freeze

The Third Circuit Court did not allow Johnson & Johnson to keep the automatic stay in place while it appeals the loss of its bankruptcy case to the U.S. Supreme Court. This stay had stopped thousands of talc lawsuits, halting any new filings since the time J&J spun off its talc liabilities into a bankrupt subsidiary. So now, pending and new cases against J&J can move on. It is another serious roadblock in the company’s strategy of attempting to use bankruptcy to thwart litigation efforts.

April 1, 2023: J&J Plans to Appeal to the Supreme Court

Johnson & Johnson has announced their intent to appeal their bankruptcy defeat to the U.S. Supreme Court. The company hopes the Supreme Court will overrule the 3rd Circuit’s decision that blocked it from using bankruptcy to manage talc liabilities. However, legal experts are speculating that this appeal would probably not be entertained by the Supreme Court, thus leaving J&J’s broader strategy on uncertain grounds.

February 14, 2023: Judge Moves to Dismiss J&J Bankruptcy Case

On Thursday, Judge Kaplan, who presides over Johnson & Johnson’s bankruptcy, declared his intentions to close the bankruptcy case following the Third Circuit’s ruling that the use of bankruptcy to deal with talc claims was improper.

February 8, 2023: New Judge Assigned to Talcum Powder MDL

Judge Michael Shipp presumes to be the judge in the MDL for talc baby powder litigation since Judge Freda Wolfson retired after handling the talc MDL case for seven years.

January 30, 2023: Court Rejects J&J’s Bankruptcy Attempt

The Third Circuit released a faint screech: it dismissed the application for Chapter 11 by J&J because it was apparently trying to extract its talc liabilities into a subsidiary that existed merely on paper. There was a corresponding crash in the company’s stock following this announcement, with plans for a Supreme Court appeal.

December 25, 2022: 3rd Circuit Oral Arguments

Judges sitting at the 3rd Circuit hearing raised questions regarding the merits involved in the J&J “bankruptcy to escape bankruptcy” scheme, thus indicating doubts regarding the validity of the maneuver.

September 20, 2022: Court Expresses Doubts Over J&J’s Bankruptcy Spin-Off

During oral arguments, appellate judges pressed J&J’s lawyers on the bad faith behind the bankruptcy for a frivolous litigation advantage. Observers noted that the judges appeared sceptical, along with implications for talc settlement cases to come.

Frequently Asked Questions on Talcum Powder Lawsuit